Valion Bio reports positive safety data
Valion Bio showed no toxicity in a government-funded Entolimod study. This safety data de-risks the drug development and supports moving toward a planned efficacy trial.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed